Skip to main content
Amid a record-breaking earnings season, tech companies are seeking to future-proof their earnings growth by investing in private healthcare, autonomous mobility, and climate tech companies

All eyes are on Big Tech companies and their earnings

Google, Apple, Microsoft, Facebook, and Amazon report second quarter earnings this week and are likely to announce record or near-record profitability and earnings growth rates. It might be easy to dismiss this as a one-off quarter because of the challenging second quarter in 2020 and the acceleration of all things digital during the pandemic. But what’s stunning is that these megacap behemoths that account for $6.7 trillion of market cap have been reporting stellar earnings growth for years, with quarterly revenue growth averaging over 20% since 2011. This growth rate might be expected for younger, quickly accelerating businesses but for large, established businesses, it’s extraordinary.


What’s behind Big Tech’s growth – and can it continue?

The rising adoption of cloud, e-commerce, and digital advertising is behind the robust growth of Big Tech, and much of this growth is still ahead. Worldwide spending on public cloud services is forecast to grow 18.4% in 2021,1 and e-commerce penetration is expected to reach 19.5% globally in 2021 and 21.8% by 2024, up from 18% in 2020 (and 13.6% in 2019).2 Digital ad spending, which represented 58.2% of total media ad spending in 2020, is set to increase by 20.4% in 2021.3

Clearly, the runway for future adoption of these technologies remains long, especially in parts of the emerging markets. But for other, newer technologies like artificial intelligence (AI), digital healthcare, autonomous future (in mobility, delivery, and more), and climate tech, the runway is even longer. Big tech companies are deploying capital and investing in these technologies to future-proof their ability to drive robust earnings growth for years to come.

If you think the recently announced Carlyle Group’s latest targeted fund raise of $27 billion – the industry’s largest ever4 – is a big deal, just think about how far $500 billion of big tech cash could go. Indeed, big tech investments hit a record in 2020 as these companies put their cash to work. They are on pace for another record year in 2021 with 36 investments made to date (through Q1), compared to 38 for all of 2020.5 Here are some areas of focus and (mostly) private companies within them that have attracted big tech investments:

  • Healthcare: During the pandemic, Google’s DeepMind artificial intelligence algorithm made a huge leap forward in using AI to determine the 3D shapes of proteins amid the tech giant’s bid to expand its reach in healthcare. The company also backed conversational AI and mental health companion Wysa and AI-powered precision oncology company Tempus. As data growth in healthcare is outpacing data growth in all other sectors, applying AI to make sense of it, well … makes a lot of sense.
  • Autonomous and carbon-free mobility: In June 2020, Amazon acquired self-driving vehicle developer Zoox for $1.3 billion. The company also backed Infinium, a maker of net zero carbon fuels, and made follow-on investments into all-electric truck and SUV maker Rivian as well as UK-based online food delivery platform Deliveroo.
  • Climate tech: Microsoft recently led a corporate minority funding round to carbon capture firm Climeworks and backed carbon removal company CarbonCure Technologies’ Series E funding round. Carbon capture and sequestration is a technology with significant potential – IEA estimates that carbon capture will account for nearly 15% of the cumulative reduction in emissions by 2070.6


Investing to maintain earnings growth power

It’s not a surprise that, to maintain their ability to deliver impressive earnings growth and avoid being disrupted, big tech companies are keenly focusing on investing for the future – either organically or through acquisitions and investments. The five big tech companies are projected to grow at an average two-year EPS CAGR of 21%. When adjusted for this growth, valuations for some of these tech names (on a PEG ratio basis) are cheaper than the S&P 500. Additionally, given recent acquisitions and investments, the true growth potential of big tech is likely underappreciated and should become more evident in earnings as these newer businesses scale up.

Big tech has been a pandemic trade, but given the investments described above, we believe it’s much more than that. Investing in these companies is effectively buying optionality on the future widespread adoption of new technologies like AI, digital health, autonomous mobility, and climate tech, while benefitting from strong existing cash flow today.


Investing in – and alongside – big tech

Public market investors may want to consider sticking with their big tech positions given this cash flow visibility and continued attractive earnings potential. For private market participants, investing alongside big tech companies in their areas of interest should provide exposure to long-term growth opportunities. Not only are the valuations more attractive in private markets, but the opportunity set is much broader – with the majority of companies that could be the next Square in Fintech, Moderna in Biotech, and Tesla in clean energy/electric cars still privately held. This is why big tech is looking for investments in private markets, and so would we.

Was this article helpful?

(1) Source: Gartner, November 17, 2020.
(2) Source: eMarketer, Dec 2020.
(3) Source: eMarketer, April 29, 2021.
(4) Source: Bloomberg, July 22, 2021.
(5) Source: CB Insights, The Big Tech Report, July 2021.
(6) Source: IEA, Special Report on Carbon Capture Utilization and Storage, 2020


This material is provided for informational purposes only and is not intended as, and may not be relied on in any manner as legal, tax or investment advice, a recommendation, or as an offer to sell, a solicitation of an offer to purchase or a recommendation of any interest in any fund or security offered by Institutional Capital Network, Inc. or its affiliates (together “iCapital Network”). Past performance is not indicative of future results. Alternative investments are complex, speculative investment vehicles and are not suitable for all investors. An investment in an alternative investment entails a high degree of risk and no assurance can be given that any alternative investment fund’s investment objectives will be achieved or that investors will receive a return of their capital. The information contained herein is subject to change and is also incomplete. This industry information and its importance is an opinion only and should not be relied upon as the only important information available. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed, and iCapital Network assumes no liability for the information provided.

This presentation contains forward looking statements. Forward looking statements include, but are not limited to assumptions, estimates, projections, opinions, models and hypothetical performance analysis. Forward looking statements involve significant elements of subjective judgments and analyses and changes thereto and/or consideration of different or additional factors could have a material impact on the results indicated. Due to various risks and uncertainties, actual results may vary materially from the results contained herein. No representation or warranty is made by iCapital as to the reasonableness or completeness of such forward looking statements or to any other financial information contained herein.

Products offered by iCapital Network are typically private placements that are sold only to qualified clients of iCapital Network through transactions that are exempt from registration under the Securities Act of 1933 pursuant to Rule 506(b) of Regulation D promulgated thereunder (“Private Placements”). An investment in any product issued pursuant to a Private Placement, such as the funds described, entails a high degree of risk and no assurance can be given that any alternative investment fund’s investment objectives will be achieved or that investors will receive a return of their capital. Further, such investments are not subject to the same levels of regulatory scrutiny as publicly listed investments, and as a result, investors may have access to significantly less information than they can access with respect to publicly listed investments. Prospective investors should also note that investments in the products described involve long lock-ups and do not provide investors with liquidity.

iCapital may have issued, and may in the future issue, material that is inconsistent with, and reaches different conclusions from, the information presented in this document. Those documents reflect the different assumptions, views, and analytical methods of the analysts who prepared them and iCapital is under no obligation to ensure that such other reports are brought to the attention of any recipient of this document.

Securities may be offered through iCapital Securities, LLC, a registered broker dealer, member of FINRA and SIPC and subsidiary of Institutional Capital Network, Inc. (d/b/a iCapital Network). These registrations and memberships in no way imply that the SEC, FINRA or SIPC have endorsed the entities, products or services discussed herein. iCapital and iCapital Network are registered trademarks of Institutional Capital Network, Inc. Additional information is available upon request.

© 2021 Institutional Capital Network, Inc. All Rights Reserved.

Back to Investment & Market Strategy
Anastasia Amoroso

Anastasia Amoroso

Anastasia Amoroso is a Managing Director and the Chief Investment Strategist at iCapital. In this role, she is responsible for providing insight on private and public market investing opportunities for advisors and their high-net-worth clients. Previously, Anastasia was an Executive Director and the Head of Cross-Asset Thematic Strategy for J.P. Morgan Private Bank, where she identified and invested in emerging technologies and disruptive trends such as artificial intelligence, decarbonization, and gene therapy. She also developed global tactical ideas and implemented institutional-level implementation across asset classes for clients. Anastasia regularly appears on CNBC and Bloomberg TV and is often quoted in the financial press. See Full Bio.